Articles by Helmut Beierbeck:

Barley Beta-Glucan Fiber Lowers Coronary Heart Disease Risk (NewsTarget) The U.S. Food and Drug Administration (FDA) recently granted Cargill, Inc. the right to make health claims for their beta-fiber product Barliv, a β-glucan (beta-glucan) extract from whole barley flour (1, 2). This so-called interim...

Flaxseed Phytoestrogens Benefit Diabetes and Cardiovascular Disease (NewsTarget) Whole flaxseeds are known to lower total and LDL cholesterol levels, reduce postprandial glucose absorption, decrease some markers of inflammation, and raise serum levels of omega-3 fatty acids (1). This is of obvious benefit to diabetics...

Antioxidants Are Lifesaving for Diabetics with Cardiovascular Disease (NewsTarget) Atherosclerosis starts with the deposition of low-density lipoproteins (LDL or “bad cholesterol”) in blood vessel walls. However, LDL deposits by themselves do not cause atherosclerosis. LDL lipids have to be oxidatively damaged before cardiovascular...

Heart Disease and the Aborted Trial of a Drug to Raise HDL (NewsTarget) Cardiovascular disease is the leading cause of death in North America and other parts of the world with a western diet and lifestyle. High cholesterol levels have taken most of the blame, and statin drugs to lower LDLs ("bad cholesterol")...

A New Understanding of the Effect of Vitamin C on Cancer Cells (NewsTarget) More than thirty years ago Linus Pauling and coworkers pioneered the therapeutic use of high doses of vitamin C (ascorbate) on terminal cancer patients, with promising results. Attempts by mainstream medicine to confirm Pauling’s results...